Upgrade to SI Premium - Free Trial

Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)

August 26, 2026 9:20 AM
Piper Sandler analyst Jessica Tassan reiterated an Overweight rating and $113.00 price target on CVS Health (NYSE: CVS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments